Skip to content

Clinical trials

Phase 2 Anemia, Sickle Cell trials in Lebanon

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 2 Country / region: Lebanon Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20131
20141
20152
20161
20171
20181
20191
20201
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Forma Therapeutics, Inc.2
HemaQuest Pharmaceuticals Inc.2
Novartis Pharmaceuticals2
Cardurion Pharmaceuticals, Inc.1
Cyclerion Therapeutics1
Hoffmann-La Roche1
Modus Therapeutics AB1
Novo Nordisk A/S1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell17
Anemia2
Vaso-Occlusive Crises2
beta-Thalassemia2
Albuminuria1
Anemia, Hemolytic1
COVID-191
Genetic Diseases, Inborn1
Hematologic Diseases1
Hemoglobin SC Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.